Neutral postgrafted colloidal particles for gene delivery

Bioconjugate Chemistry

Volumn 16, Issue 3, 2005, Pages 608-614

  Thompson, B ^a   Mignet, N ^a,d   Hofland, H ^b   Lamons, D ^b   Seguin, J ^a   Nicolazzi, C ^a   De La Figuera, N ^a   Kuen, R L ^c   Meng, X Y ^b   Scherman, D ^a   Bessodes, M ^a  

^a CNRS   (France)

^b AVANIR PHARMACEUTICALS   (United States)

^c Faculte de Pharmacie   (France)

^d Centre National de la Recherche Scientifique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; CHOLESTEROL; GENE TRANSFER; LIGANDS; LIPOSOMES; SURFACE TREATMENT;

CATIONIC LIPIDS; CATIONIC LIPOPLEXES; COLLOIDAL PARTICLE; GENE DELIVERY; LIPID A; NEUTRAL LIPID; POST-GRAFTING REACTIONS; SURFACE-MODIFICATION; TARGETING LIGANDS;

POLYETHYLENE GLYCOLS;

CATION; LIGAND; LIPOPLEX; LIPOSOME; MACROGOL;

ANIMAL TISSUE; ARTICLE; CELL SURFACE; CONTROLLED STUDY; FEMALE; GENE TARGETING; IN VITRO STUDY; LUNG; MOUSE; NEUTRAL GENE THEORY; NONHUMAN; PARTICLE SIZE; ZETA POTENTIAL;

EID: 21044453296     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc040244z     Document Type: Article

References (19)

1. Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., Ringold, G. M., and Danielsen, M. (1987) Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. U.S.A. 84, 7413-7417.
2. Maurer, N., Mori, A., Palmer, L., Monck, M., Mok, K., Mui, B., Akhong, Q., and Cullis, P. (1999) Lipid-based systems for the intracellular delivery of genetic drugs. Mol. Membr. Biol. 16, 129-140.
3. Papahadjopoulos, D., Allen, T. A., Gabizon, A., Mayhew, E., Matthay, K., Huang, S., Lee, K., Woodle, M., Lasic, D., Redemann, C., and Martin, F. (1991) Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. U.S.A. 88, 11460-11464.
4. Song, L., Ahkong, Q., Rong, Q., Wang, Z., Ansell, S., Hope, M., and Mui, B. (2002) Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes. Biochim. Biophys. Acta 1558, 1-13.
5. Nicolazzi, C., Mignet, N., de la Figuera, N., Cadet, M., Torero Ibad, R., Seguin, J., Scherman, D., and Bessodes, M. (2003) Anionic poly(ethylene glycol) lipids added to cationic lipoplexes increase their plasmatic circulation time. J. Controlled Release 88, 429-443.
6. Hofland H., Masson, C., Iginla, S., Osetinsky, I., Reddy, J. A. Leamon, C. P., Scherman, D., Bessodes, M., and Wils, P. (2002) Folate-Targeted Gene Transfer in Vivo. Mol. Ther. 5, 739-744.
7. Allen, T. (1994) Long-circulating (sterically stabilized) liposomes for targeted drug delivery. Trends Pharmacol. Sci. Rev. 15, 215-220.
8. Maruyama, K., Takizawa, T., Yuda, T., Kennel, S., Huang, L., and Iwatsuru, M. (1995) Targetability of novel immuno-liposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies. Biochim. Biophys. Acta 1234, 74-80.
9. Hansen, C., Kao, G., Moase, E., Zalipsky, S., and Allen, T. (1995) Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures. Biochim. Biophys. Acta 1239, 133-144.
10. Blume, G., Cevc, G., Crommelin, M., Bakker-Woudenberg, I., Kluft, C., and Storm, G. (1993) Specific targeting with poly-(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. Biochim. Biophys. Acta 1149, 180-184.
11. Bendas, G., Krause, A., Bakowsky, U., Vogel, J., and Rothe, U. (1999) Targetability of novel immunoliposomes prepared by a new antibody conjugation technique. Int. J. Pharm. 181, 79-93.
12. Byk, G., Scherman, D., Schwartz, B., Dubertret, C. (1997) Lipopolyamines as transfection agents and pharmaceutical uses thereof. Rhone-Poulanc Rorer, S.A., W097/18185, 81 pp.
13. Koivunen, E., Wang, B., and Ruoslahti, E. (1995) Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins. BioTechnology 13, 265-70.
14. Takeuchi, H., Kojima, K., Yamamoto, H., and Kawashima, Y. (2000) Polymer coating of liposomes with a modified poly-(vinyl alcohol) and their systemic circulation and RES uptake in rats. J. Controlled Release 68, 195-205.
15. Templeton, N. (2003) Cationic liposomes as in vivo delivery vehicles. Curr. Med. Chem. 10, 1279-1287.
16. Shi, F., Wasungu, L., Nomden, A., Stuart, M., Polushkin, E., Engberts, J., and Hoekstra, D. (2002) Interference of poly-(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and non-lamellar transitions. Biochem. J. 366, 333-341.
17. Blezinger, P., Yin, G., Xie, L., Wang, J., Matar, M., Bishop, J., and Min, W. (1999) Intravenous delivery of an endostatin gene complexed in cationic lipid inhibits systemic angiogenesis and tumor growth in murine models. Angiogenesis 3, 205-210.
18. 3 for angiogenesis. Science 264, 569-571.
19. Schiffelers, R., Koning, G., ten Hagen, T., Frens, M., Schraa, A., Janssen, A., Kok, R., Molema, G., and Storm, G. (2003) Antitumor efficacy of tumor vasculature-targeted liposomal doxorubicin. J. Controlled Release 91, 115-58.